Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Turbinmicin- A New Fighter

COVID-19 Testing Lab Recruitment For Life Sciences at NICPR

Nanoparticle mediated drug delivery – the way of the future

Turbinmicin- A New Fighter
  • BiotechToday
  • World

Turbinmicin- A New Fighter

bioxone November 28, 2020November 28, 2020

Shrayana Ghosh, Amity University Kolkata

A new antifungal compound, discovered by the scientists of the University of Wisconsin-Madison, Madison that can target the multidrug-resistant and potentially deadly strains of the fungal pathogen Candida auris without causing any toxic side effects in mice.

The team discovered a new molecule detected in the microbiome of a sea squirt from the Florida Keys. Turbinmicin was named after the sea squirt from which it was isolated, Esteinascidia turbinate, by the scientists. Turbinmicin discovery has been the tangible contribution of the five-year NIH grant of the NIH community for $30 million to find new antimicrobial products from bacteria that reside in neglected environments.

According to Tim Bugni, a PhD professor at the University of Wisconsin-Madison School of Pharmacy, bacterias are a rich source of molecules. Unlike terrestrial ecosystems, the marine bacterial diversities are investigated scarcely for drug discovery. The discoveries of Bugni and colleagues described in the paper titled, “A marine microbiome antifungal targets urgent-threat drug-resistant fungi.”

Infectious fungal diseases are one of the deadliest threats to global health. The disease-causing fungi become resistant to the three classes of antifungal drugs available for clinical use, making previously treatable diseases lethal ( Candidiasis). Due to mining of the same soil-dwelling bacterias for antimicrobial drugs, the discovery of new antifungal agents has been challenging due to the presence of the same molecules. Thus, Bugni partnered with two other Ph.D. professors of UW, David Andes and, Cameron Currie to search and isolate bacterias from neglected environments of marine for the generation of antimicrobial compounds.

The experiment proceeded with the collection of ocean-dwelling invertebrates from the Florida Keys. Nearly 1500 strains of actinobacteria, were identified out of which only 174 strains, were selected. Then the Screening tested against drug-resistant Candida. The targeted Candida auris strain was resistant against all the three existing antifungal classes. When mice infected with Candida auris was given the antifungal Turbinmicin, it showed its effectiveness against the fungus. What made Turbinmicin stand out was the absence of any toxic side-effects. The discovery of turbinmicin is also evidence of the efforts of this partnership to explore new habitats and to test thousands of candidates for antimicrobial candidates.

Also read: Threats to T-cell over-activation in response to CD28

Source-

  1. https://www.genengnews.com/news/sea-squirt-microbiome-yields-compound-effective-against-deadly-strain-of-fungal-pathogen/
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged actinobacteria Antifungal antimicrobial Candida auris Esteinascidia trubinate multidrug-resistant turbinmicin

2 thoughts on “Turbinmicin- A New Fighter”

  1. Pingback: Nanoparticle mediated drug delivery – the way of the future - BioXone
  2. Pingback: An eye exam with AI to achieve early Parkinson’s detection? - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

Nanoparticle mediated drug delivery – the way of the future

bioxone November 28, 2020

Srishti Deb, Amity University, Kolkata Nanoparticle: Technobiology’s wireless messenger – With the advancement of science and modern technologies, a more promising technology of drug delivery to selective tissues is used. This is a more potent targeted delivery process of therapeutic agents, that significantly eliminates drug or drug carrier side effects. Drug design and drug delivery […]

Nanoparticle

Related Post

  • BiotechToday
  • World

The Arctic Ocean’s past to its Near-Future

bioxone September 2, 2021September 2, 2021

Neha Khan, Jamia Millia Islamia Scientists are rushing to understand the consequences of warming on Arctic ecosystems as the North Pole, the Arctic Ocean, and surrounding Arctic land warm fast. They’re talking about nitrogen, a vital nutrient. Using fossilized plankton, the researchers examined nitrogen reasserts and delivery costs within the western and critical open Arctic […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Awareness among Saudi Women about Cancer & Carcinogens

BioTech Today May 6, 2022May 5, 2022

Rajyashree Basu, University Of Calcutta (Lady Brabourne College) Saudi Arabia has seen a rise in cancer cases through the decades- between 1999 and 2015 the cases rose by 136%, and are predicted to rise by 63% by the year 2030. The study in this discussion was aimed at exploring the knowledge of the general women […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Non-antimicrobials as Antibiotics: Wonder of Drug Repurposing

bioxone October 17, 2020October 17, 2020

Avipsha Datta, Department of Biophysics, Molecular Biology and Bioinformatics, University of Calcutta Antibiotics were considered to be “wonder drugs” in the 20th century. But, as days passed, we started the over usage of these medicines and basically helped the bacteria to become pretty clever and evade these wonder drugs, that is, they developed resistance! Antibiotic […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy